BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38611058)

  • 1. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases.
    Cargnello M; Roux PP
    Microbiol Mol Biol Rev; 2011 Mar; 75(1):50-83. PubMed ID: 21372320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Conventional and Atypical MAPKs on the Development of Metabolic Diseases.
    Kassouf T; Sumara G
    Biomolecules; 2020 Aug; 10(9):. PubMed ID: 32872540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the Atypical MAPK ERK3 in Cancer Growth and Progression.
    Elkhadragy L; Myers A; Long W
    Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERK3 is transcriptionally upregulated by ∆Np63α and mediates the role of ∆Np63α in suppressing cell migration in non-melanoma skin cancers.
    Alshammari ES; Aljagthmi AA; Stacy AJ; Bottomley M; Shamma HN; Kadakia MP; Long W
    BMC Cancer; 2021 Feb; 21(1):155. PubMed ID: 33579235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation loop phosphorylation of ERK3 is important for its kinase activity and ability to promote lung cancer cell invasiveness.
    Elkhadragy L; Alsaran H; Morel M; Long W
    J Biol Chem; 2018 Oct; 293(42):16193-16205. PubMed ID: 30166347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The C-Terminus Tail Regulates ERK3 Kinase Activity and Its Ability in Promoting Cancer Cell Migration and Invasion.
    Elkhadragy L; Alsaran H; Long W
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32516969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The atypical MAPK ERK3 potently suppresses melanoma cell growth and invasiveness.
    Chen M; Myers AK; Markey MP; Long W
    J Cell Physiol; 2019 Aug; 234(8):13220-13232. PubMed ID: 30569573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deubiquitinating Enzyme USP20 Regulates Extracellular Signal-Regulated Kinase 3 Stability and Biological Activity.
    Mathien S; Déléris P; Soulez M; Voisin L; Meloche S
    Mol Cell Biol; 2017 May; 37(9):. PubMed ID: 28167606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERK3 Increases Snail Protein Stability by Inhibiting FBXO11-Mediated Snail Ubiquitination.
    Kim SH; Ryu KJ; Hong KS; Kim H; Han H; Kim M; Kim T; Ok DW; Yang JW; Hwangbo C; Kim KD; Yoo J
    Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A de novo missense mutation in MPP2 confers an increased risk of Vogt-Koyanagi-Harada disease as shown by trio-based whole-exome sequencing.
    Liu X; Meng J; Liao X; Liu Y; Zhou Q; Xu Z; Yin S; Cao Q; Su G; He S; Li W; Wang X; Wang G; Li D; Yang P; Hou S
    Cell Mol Immunol; 2023 Nov; 20(11):1379-1392. PubMed ID: 37828081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ERK3 and DGKζ interact to modulate cell motility in lung cancer cells.
    Myers AK; Morel M; Gee SH; Hoffmann KA; Long W
    Front Cell Dev Biol; 2023; 11():1192221. PubMed ID: 37287450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased methylation of ZNF671 suppresses tumor progression by promoting MAPK6 transcription in laryngeal carcinoma.
    Zhang W; Liu T; Li X; Li T; Ma X; Zhao D; Zhao X
    Int J Biol Sci; 2023; 19(8):2443-2457. PubMed ID: 37215982
    [No Abstract]   [Full Text] [Related]  

  • 13. ERK3/MAPK6 dictates CDC42/RAC1 activity and ARP2/3-dependent actin polymerization.
    Bogucka-Janczi K; Harms G; Coissieux MM; Bentires-Alj M; Thiede B; Rajalingam K
    Elife; 2023 Apr; 12():. PubMed ID: 37057894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HNF4G increases cisplatin resistance in lung adenocarcinoma via the MAPK6/Akt pathway.
    Liang J; Zhao G; Bian Y; Bi G; Sui Q; Zhang H; Shi H; Shan G; Huang Y; Chen Z; Wang L; Zhan C
    PeerJ; 2023; 11():e14996. PubMed ID: 36923501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CircDNAJC11 interacts with TAF15 to promote breast cancer progression via enhancing MAPK6 expression and activating the MAPK signaling pathway.
    Wang B; Chen H; Deng Y; Chen H; Xing L; Guo Y; Wang M; Chen J
    J Transl Med; 2023 Mar; 21(1):186. PubMed ID: 36895010
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.